Blood thinner safety and bleeding risk: Ask the Expert with VLN Network
Join VLN Network for a special Blood Clot Awareness Month event:
Beyond the Headlines:
What You Really Need to Know about Blood Thinners
Beyond the Headlines:
What You Really Need to Know about Blood Thinners
Tuesday, March 31, 2026 7:00 p.m. - 8:00 p.m. (US-ET)
Blood thinners are among the most commonly prescribed medications in cardiovascular care — and blood thinner safety and bleeding risk are some of the most frequently discussed topics in the media. If recent headlines have left you feeling uncertain, you’re not alone.
In this Ask the Expert session from our partners at VLN Network, experts will provide clear, practical context about why these medications are prescribed, how clinicians balance clot risk and bleeding risk, and what you should understand about their safety.
This session is made possible through a partnership with the International Society on Thrombosis and Haemostasis (ISTH) and World Thrombosis Day (WTD). Together with VLN Network, ISTH and WTD are committed to bringing accurate, accessible information about blood clot prevention and treatment directly to patients and the public. This collaboration reflects a shared belief that informed patients are better equipped to have meaningful conversations with their healthcare providers and make confident decisions about their care.
This conversation is designed to provide clarity and confidence, not fear. We’ll end with a live Q&A so you can ask your questions directly. You may also submit questions in advance to cbattaglia@thrombosis.org.
Please note: This session will be recorded. The experts cannot provide personalized medical advice.
Hosted by VLN Network:
- Arthur L. Allen, PharmD, CACP — Anticoagulation Program Manager, VA Salt Lake City Health Care System
- Tara K. Lech, PharmD, CACP — Medical Advisory Board Co-Chair & Clinical Pharmacy Specialist, Beth Israel Lahey Health
- Scott C. Woller, MD — Internist and thrombosis researcher Intermountain Health, University of Utah School of Medicine
To register for the event, please click the button below.
Share this post, choose a platform
Related Campaign News
Join VLN Network for a special Blood Clot Awareness Month event: [...]
MEDIA RELEASE Safer blood clot treatment with apixaban than with rivaroxaban, [...]
The Russian Anti-Thrombotic Forum continues to strengthen its position as one [...]

